Physician profile
Karissa Bourbeau
NPI 1720600034
$473.18
in general payments reported to CMS, 2019-2025
7 companies · $135 in 2025
The $135 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.67 · 2023: $37.10 · 2024: $288 · 2025: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $460.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $253.35 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Shionogi INC | $118.60 | 2025 | Fetroja |
| Smith+Nephew, INC. | $34.46 | 2024-2025 | Collagenase Santyl |
| Convatec INC. | $19.54 | 2023 | |
| Ethicon US, LLC | $17.56 | 2023 | Echelon; Endopath, Surgicel Nu-Knit |
| Astrazeneca Pharmaceuticals Lp | $17.00 | 2024 | Andexxa |
| Ucb, INC. | $12.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karissa Bourbeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.